Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia. [electronic resource]
Producer: 20021127Description: 184-90 p. digitalISSN:- 0361-8609
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Cell Count
- Cytogenetic Analysis
- Disease Progression
- Dose-Response Relationship, Drug
- Humans
- Imatinib Mesylate
- Leukemia, Myeloid, Accelerated Phase -- drug therapy
- Megakaryocytes -- pathology
- Piperazines -- administration & dosage
- Pyrimidines -- administration & dosage
- Thrombocytopenia -- chemically induced
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.